Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Multicenter Trial Of Pentostatin and Rituximab In Patients With Previously Treated and Untreated Low Grade B-Cell Non-Hodgkin's Lymphoma (NHL) Including Chronic Lymphocytic Leukemia (CLL)

NCT00026351 is registered in ClinicalTrials.gov with Pharmatech Oncology as lead sponsor.

NCT NCT00026351
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00026351 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Multicenter Trial Of Pentostatin and Rituximab In Patients With Previously Treated and Untreated Low Grade B-Cell Non-Hodgkin's Lymphoma (NHL) Including Chronic Lymphocytic Leukemia (CLL)
Lead sponsor
Pharmatech Oncology
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2000
Completion date
June 30, 2003
Enrollment
Not reported
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, lymphoma